|
Real-time Estimate
Cboe BZX
19:22:05 03/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.750 USD | +3.37% |
|
+1.50% | +114.97% |
| 10-25 | Agenus Inc. Reports Early Phase 2 Results From dMMR Colon Cancer Cohort Of NEOASIS Study | CI |
| 10-08 | Agenus Gets Armenia Approval for Botensilimab-Balstilimab Combination | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AGEN | Delayed | |
Tradegate
| AJ8 | Real-time | |
|
CBOE
| AGEN | Real-time | |
|
Deutsche Boerse AG
| AJ8 | Delayed | |
|
Boerse Muenchen
| AJ8 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 7.67 | 9.93 | 8.54 |
| Spread/Res. | -11.99% | -32.02% | -20.96% |
| Spread/Supp. | +11.75% | +22.06% | +40.92% |
| Support | 6.04 | 5.53 | 4.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AGEN Stock
- Charts Agenus Inc.
Select your edition
All financial news and data tailored to specific country editions
